Human Peripheral Blood Mononuclear Cells Exhibit Heterogeneous CD52 Expression Levels and Show Differential Sensitivity to Alemtuzumab Mediated Cytolysis

Alemtuzumab is a monoclonal antibody that targets cell surface CD52 and is effective in depleting lymphocytes by cytolytic effects in vivo. Although the cytolytic effects of alemtuzumab are dependent on the density of CD52 antigen on cells, there is scant information regarding the expression levels...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Hoofdauteurs: Rao, Sambasiva P., Sancho, Jose, Campos-Rivera, Juanita, Boutin, Paula M., Severy, Peter B., Weeden, Timothy, Shankara, Srinivas, Roberts, Bruce L., Kaplan, Johanne M.
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: Public Library of Science 2012
Onderwerpen:
Research Article
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC3382607/
https://ncbi.nlm.nih.gov/pubmed/22761788
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0039416
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items